The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Children's National Research Institute
- Study ID
- NCT06623981
- Status
- Recruiting
Conditions
- Asthma in Children
- Depression
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Enhanced Brief Interpersonal Psychotherapy — BEHAVIORALEnhanced IPT-B consists of a single, 45-60-minute pre-treatment engagement session followed by eight weekly, 45-minute individual sessions carried out within an 8-12-week timeframe.
- Supplemented Usual Care — BEHAVIORALUsual care for caregivers with depressive symptoms involves the asthma clinic physician discussing the PHQ-9 results with the caregiver, providing brief psychoeducation on depression and giving the caregiver a written list of mental health resources. Usual care will be supplemented by providing short-term care coordination. Care coordination will involve assisting the participant in calling a mental health clinic to make an appointment and one follow-up phone call within two weeks.
Study Details
The goal of this clinical trial is to test the effectiveness and implementation of delivering Enhanced Brief Interpersonal Psychotherapy (IPT-B), an evidence-based maternal depression treatment, to mothers of children under the age of 18 in an urban pediatric asthma clinic. Researchers will compare Enhanced IPT-B and supplemented usual care (brief care coordination). The main questions the trial aims to answer are: 1. Does Enhanced IPT-B decrease maternal depressive symptoms? 2. Does Enhanced IPT-B improve child asthma management and health outcomes (exacerbations, symptoms, control)? 3. What are the preliminary implementation outcomes of delivering Enhanced IPT-B in an urban pediatric asthma clinic?
Key Dates
- Start date
- Oct 15, 2024
- Status verified
- Feb 2026
- Primary completion
- Dec 15, 2026
- Completion
- Mar 15, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Enhanced IPT-BEnhanced Brief Interpersonal Psychotherapy
- Active Comparator: Supplemented Usual CareShort-term care coordination
Primary Outcome Measure
Maternal depressive symptoms [ Time Frame: T2 (3 months post-baseline) ]
Central Contacts
- Geraldine Mendez-Gonzalez(202) 476-6956
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's National Hospital | Washington D.C. | District of Columbia | 20010 | Rachel Margolis, PhD, MSW (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Washington D.C., DC
Related Studies
- Omalizumab Before Onset of ExacerbationsPHASE2 · Recruiting · Children's National Research Institute · Washington D.C., District of Columbia
- Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma CareRecruiting · Kavita Parikh · Washington D.C., District of Columbia
- E-Mindfulness Approaches for Living After Breast CancerPHASE3 · Recruiting · NRG Oncology · Phoenix, Arizona
- Evaluation of Patients With Mood and Anxiety Disorders and Healthy VolunteersRecruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland